445303-69-5

Basic information

• Product Name: 4-BROMO-2-DIFLUOROMETHYL-1-FLUOROBENZENE
• Synonyms: 4-BROMO-2-DIFLUOROMETHYL-1-FLUOROBENZENE;4-BROMO-1-FLUORO-2-(DIFLUOROMETHYL)BENZENE;5-BROMO-2-FLUORO-1-(DIFLUOROMETHYL)BENZENE;4-BROMO-1-FLUORO-2-(DIFLUOROMETHYL)BENZENE, 97% MIN.;3-(Difluoromethyl)-4-fluoro-1-bromobenzene;4-Bromo-2-(difluoromethyl)-1-fluorobenzene 97+%;1-Bromo-4-fluoro-3-(difluoromethyl)benzene
• CAS NO: 445303-69-5
• Molecular Formula: C₇H₄BrF₃
• Molecular Weight: 225.01
• Product Categories: Fluorine series
• Mol File: 445303-69-5.mol

Chemical Properties

• Boiling Point: 188℃
• Flash Point: 75℃
• Appearance: /
• Density: 1.633
• Vapor Pressure: 0.838mmHg at 25°C
• Refractive Index: 1.48
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-BROMO-2-DIFLUOROMETHYL-1-FLUOROBENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-2-DIFLUOROMETHYL-1-FLUOROBENZENE(445303-69-5)
• EPA Substance Registry System: 4-BROMO-2-DIFLUOROMETHYL-1-FLUOROBENZENE(445303-69-5)

Safety Data

• Hazardous Substances Data: 445303-69-5(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
4-Bromo-2-difluoromethyl-1-fluorobenzene is used as a building block in organic synthesis for the creation of a variety of pharmaceuticals and agrochemicals. Its unique structure allows for the development of new compounds with potential applications in various fields.
Used in Pharmaceutical Research:
In pharmaceutical research, 4-Bromo-2-difluoromethyl-1-fluorobenzene is utilized as a key intermediate for the synthesis of fine chemicals and pharmaceuticals. Its properties make it a valuable component in the development of new drugs and therapeutic agents.
Used in the Production of Fine Chemicals and Pharmaceuticals:
4-Bromo-2-difluoromethyl-1-fluorobenzene is employed as an intermediate in the production process of fine chemicals and pharmaceuticals. Its presence in these processes is crucial for the synthesis of end products with specific therapeutic or chemical properties.
Safety Considerations:

InChI:InChI=1/C7H4BrF3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,7H

Upstream product

• 144-55-8 sodium hydrogencarbonate 
• 93777-26-5 5-bromo-2-fluorobenzaldehyde 

Relevant articles and documents

KINASE ANTAGONISTS AND METHODS FOR MAKING AND USING THEM

Disclosed herein are small molecule compounds that are SGK1 antagonists, formulations and pharmaceutical compositions comprising the compounds, and methods of making and using them, for treating, ameliorating, preventing, reversing or slowing the progression of: a cancer, a tumor, a metastasis or a dysplastic or a dysfunctional cell condition responsive to inhibition of a kinase enzyme of the AGC group of kinases including SGK1, by administration of an AGC kinase inhibitor or antagonist.

DISUBSTITUTED PHENYLPIPERIDINES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION

The present invention relates to compounds of the formulae (4), (5) or (6), and their use in the treatment of central nervous system disorders.

Substituted imidazol-pyridazine derivatives

The present invention relates to compounds of formula wherein A is an unsubstituted or substituted cyclic group; and R is hydrogen or lower alkyl; or a pharmaceutically acceptable acid addition salt thereof. These compounds are NMDA NR-2B receptor subtype specific blockers and are useful in the treatment of neurodegeneration, depression and pain.

Imidazole derivatives

Novel imidazole derivatives are disclosed. These compounds have a good affinity to the NMDA (N-methyl-D-aspartate)-receptor subtype selective blockers, which have a key function in modulating neuronal activity and plasticity which makes them key players in mediating processes underlying development of CNS as well as learning and memory formation. These compounds are useful in the control or treatment of diseases mediated by this receptor.